FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 331:617 September 1, 1994 Number 9 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Armitage, J. O.

To the Editor: In his review on bone marrow transplantation (March 24 issue),¹ Dr. Armitage has provided an excellent overview of transplantation therapy for hematologic cancers, with a brief discussion of preliminary results when the technique is used for solid tumors. He stated that "for the treatment of... small-cell lung cancer, the results of transplantation have been sufficiently discouraging to preclude further clinical trials."

Previous trials of high-dose therapy for small-cell lung cancer were noted for their high mortality rates, frequent use of single agents in high doses, or lack of chest radiotherapy, resulting in relatively poor overall results and . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.